Mesoblastic Nephroma clinical trials at UCSF
2 in progress, 1 open to eligible people
Mesoblastic nephroma is a kidney tumor that starts before or soon after birth. UCSF is keeping health data from infants and children with this tumor over time. This includes treatment details and follow-up clinic visits.
Project: Every Child for Younger Patients With Cancer
open to eligible people ages up to 25 years
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
Oakland, California and other locations
Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
Sorry, in progress, not accepting new patients
This is an open-label, Phase 1/2 multicenter dose escalation study in pediatric patients with relapsed or refractory extracranial solid tumors (Phase 1), with additional expansion cohorts (Phase 2) in patients with primary brain tumors harboring NTRK1/2/3 or ROS1 gene fusions, and extracranial solid tumors harboring NTRK1/2/3 or ROS1 gene fusions.
San Francisco, California and other locations
Our lead scientists for Mesoblastic Nephroma research studies include Jennifer G. Michlitsch Arun A. Rangaswami.
Last updated: